About 75% of epithelial ovarian cancer (EOC) patients suffer from relapsing and develop
drug resistance after primary chemotherapy. The commonly used clinical examinations and …

Identifying drug-resistant cancer cells is of fundamental importance to afford disease and
find the most effective therapies for the patients. Recently, label-free imaging flow cytometry …

Nowadays, label-free imaging flow cytometry at the single-cell level is considered the
stepforward lab-on-a-chip technology to address challenges in clinical diagnostics, biology …

The noninvasive, fast acquisition of quantitative phase maps using digital holographic
microscopy (DHM) allows tracking of rapid cellular motility on transparent substrates. On two …

Cell studies play an important role in the basis of studies on cancer diagnosis and treatment.
Reliable viability assays on cancer cell studies are essential for the development of effective …

Holographic cytometry is an ultra-high throughput quantitative phase imaging modality that
is capable of extracting subcellular information from millions of cells flowing through parallel …

Platinum chemosensitivity detection plays a vital role during endometrial cancer treatment
because chemotherapy responses have profound influences on patient's prognosis …

To efficiently tackle certain tumor types, finding new biomarkers for rapid and complete
phenotyping of cancer cells is highly demanded. This is especially the case for the most …

Large-scale and label-free phenotyping of cells holds great promise in medicine, especially
in cancer diagnostics and prognosis. Here, we introduce inline digital holography …

Digital holographic cytometry (DHC) permits label-free visualization of adherent cells.
Dozens of cellular features can be derived from segmentation of hologram-derived images …